International Aid Group Fights Parasites in Brazil
SAO PAULO, Brazil - Officials from INMED are working to help some 2 million Brazilian children infected with intestinal parasites.
For US$5 per child, the drug mebendazole can kill the bugs, which deplete children of vitamin A and iron. The U.S.-based international health and development organization created the Healthy Children, Healthy Futures program to combine public and private monies to aid impoverished public health.
Officials from the World Health Organization estimate that 90 percent of children in rural Brazil are infected with these parasites. Because they are transmitted via soil and water, the organization teaches how to maintain their health after the medication is given. These lessons include information on hand washing, wearing shoes, corralling animals and washing fruits and vegetables.
INMED also works in Mexico, the Dominica Republic, Burkina Faso, Chile, Ecuador, Bolivia, Guatemala, Honduras, the Philippines and India.
For additional information, call Marshall Hoffman at (703) 820-2244.
Together We Rise: Why AORN Expo 2025 Is a Must for Every Perioperative Nurse
March 31st 2025From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
